Cyriano Health & Wellness Center
Cyriano Health & Wellness Center · 74 U.S. 9 · Englishtown, NJ 07726
5.0· 35 Google reviews
Listing updated October 2, 2026
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Care described on the practice's website
- Medically supervised weight loss
About this practice
Cyriano Health & Wellness Center is a health and aesthetics practice in Englishtown, New Jersey. Its website describes personalized, evidence-based care through functional medicine, hair restoration and supportive aesthetics, lists weight-loss plans it says can be chosen around goals, schedule and budget, and names Dr. Okwuolisa Ikediobi, MD. The listing also shows IV therapy. On Google it has a 5.0-star rating across 35 reviews dating back to 2022, with 4 in the past year; reviewers most often mention the providers' knowledge and results, in 13 and 12 reviews.
Services & access
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Not listed |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-12. Read the reviews themselves on the practice's Google listing.
What patients say
Rated ★5.0 across 35 Google reviews. Of the 35 reviews we analyzed, 35 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).
What patients like
- Knowledgeable, professional providers13 reviews
- Weight-loss results12 reviews
- Friendly, helpful staff8 reviews
- Feeling listened to7 reviews
Common complaints
No negative reviews among those we analyzed.
Most recent Google reviews
Tyler J.★★★★★2026-09-12I had a FUE procedure done with Ashli and her team and the experience was great. They are very kind, patient, and explained everything. They encourage you to ask as many questions as you want which I appreciated. After my procedure, Ashli followed up with me every day to check on my recovery progress.
Ashleigh K.★★★★★2026-07-29This is one of the best health and wellness centers in the area! Dr. Ashli Cyriano is so warm and welcoming and is always looking out for your best interest as the patient! I've been coming here for the Lipotropic Vitamin Cocktail shots and they've helped me so much so far with my weight loss journey!
Michelle D.★★★★★2026-05-12Ashley has been very instrumental in my weight loss journey. I’m down over 30 pounds! She answers questions and helps you safely lose weight and maintain a healthy lifestyle to keep it off. I highly recommend!
NANAKB A.★★★★★2026-05-095 stars without hesitation. Had my hair transplant with Cyriaano health 6 months ago and I couldn’t be happier. The team was professional, explained everything, and the results look completely natural. My confidence is back. If you’re considering it, book the consult. Worth every penny.
Bernard A.★★★★★2025-04-09I had my hair transplant done 4 months ago and I couldn’t be happier with the results! The growth has been steady and natural-looking, and I’m already seeing a huge boost in my confidence. The clinic was professional, clean, and the staff made me feel comfortable every step of the way. Highly recommend to anyone considering a hair transplant!
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs